Publication | Closed Access

Metformin 2,500 mg/day in the treatment of obese women with polycystic ovary syndrome and its effect on weight, hormones, and lipid profile

ObesityMetabolic SyndromeMetabolic DisorderMedicineDiabetesObese WomenObesity ManagementGynecologyPolycystic Ovary SyndromeEndocrinologyPharmacologyMetformin 2,500Women's HealthHealth Sciences